Telomeres and telomerases in cancer.
Novak
Kristine D
KD
Nature Reviews Cancer, New York, NY, USA.
D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002460:Cell Line; D016922:Cellular Senescence / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D002869:Chromosome Aberrations / Q000187:drug effects; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D008297:Male; D051379:Mice; D008957:Models, Genetic; D009101:Multiple Myeloma / Q000201:enzymology / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000209:etiology / Q000235:genetics*; D009841:Oligonucleotides / Q000627:therapeutic use; D009928:Organ Specificity / Q000235:genetics / Q000502:physiology; D010190:Pancreatic Neoplasms / Q000201:enzymology / Q000235:genetics; D011471:Prostatic Neoplasms / Q000201:enzymology / Q000235:genetics; D019098:Telomerase / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D016615:Telomere / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics* / Q000502:physiology; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000502:physiology
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D009841:Oligonucleotides; D016159:Tumor Suppressor Protein p53; D019098:Telomerase